Prince Kannankeril Archives
High blood pressure genes improve heart surgery survival in children
Mar. 24, 2022—Vanderbilt researchers have found that children with a genetic makeup that predicts high blood pressure as adults are more likely to survive congenital heart defect repair surgery.
Kannankeril named inaugural holder of the Richard B. Johnston Jr., MD, Chair in Pediatric Research
Sep. 22, 2021—Prince Kannankeril, MD, MSCI, has been appointed inaugural holder of the Richard B. Johnston Jr. MD, Chair in Pediatric Research at Vanderbilt University Medical Center.
Grant creates center for maternal, pediatric precision therapeutics
Sep. 17, 2021—Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics.
Tailoring treatment for heart defect
Sep. 23, 2019—By defining the clinical and genetic factors that predict treatment response, Vanderbilt investigators aim to personalize therapy for a common heart complication in preterm infants.
Kannankeril elected VP for research of the Pediatric and Congenital Electrophysiology Society
May. 29, 2019—Prince Kannankeril, MD, MSCI, has been elected to serve as vice president for research of the Pediatric and Congenital Electrophysiology Society.
Risk factors for faulty rhythms
Aug. 16, 2018—Risk factors for arrhythmias after heart surgery in infants include medications, infant age and higher surgical complexity, but not two genetic variants examined by Vanderbilt researchers.
Mutation raises heart block risk
Mar. 3, 2017—A newly identified genetic risk factor for heart block after surgery may help guide the course of postoperative care.
